Apr. 6 at 4:21 PM
$NUVB even with the stupid war ongoing and macro market daily fluctuations crazy, M&A in biotech is continuing to be hot. Not much we retails can do but focus on fundamentals in individual ticker.
Think about the
$592 M cash we had by 12/31/25 and the promise Hung made “no needs for dilutions at all” And most importantly to me that he owns over 61 Million shares in the company he runs daily operations himself. I don’t know exact SP average he has but most likely he’s in red at
$4.6 right now. He’s a very intelligent and hard working business man who wants to prove that Medivation deal was not one time lucky charm and Axovant disaster was not his fault…
So let him work on it.
Don’t lose faith and hold your shares. BLTA
https://www.fiercepharma.com/pharma/neurocrine-strikes-29b-soleno-buyout-its-largest-ma-ever-eyeing-blockbuster-rare-disease
